The Benchmark Company’s Senior Equity Analyst, Aydin Huseynov, M.D., CFA. on emergency use of convalescent plasma to treat COVID-19
The Benchmark Company’s Senior Equity Analyst, Mike Ward discussing Capacity and the Commercial Segment of the Market Favor Ford and GM in the EV Wars
